Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
IMVT
#1145
Immunovant, Inc. Common Stock
27.730
0
+3.28%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+3.28%
Monatliche Änderung
+3.47%
6 month change
+44.35%
Jahresänderung
+44.35%
Vorheriger Schlusskurs
26.850
0
Open
27.730
0
Bid
Ask
Low
27.730
0
High
27.730
0
Volumen
113
Märkte
Aktien
Gesundheitswesen
IMVT
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
97.98 M
116.51 M
130.41 M
146.05 M
170.92 M
—
Valuation ratios
Enterprise value
1.17 B
148.14 M
1.65 B
3.98 B
2.21 B
10.88 B
Price to earnings ratio
—
-3.85
-9.07
-16.81
-6.26
-27.08
Price to sales ratio
—
—
251.9
174.98
—
—
Price to cash flow ratio
—
-5.7
-10.14
-20.38
-6.89
-28.79
Price to book ratio
—
1.29
5.27
7.07
3.66
7.52
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.3
0.52
0.39
0.53
0.64
Return on equity %
0.27
0.33
0.58
0.42
0.58
0.7
Return on invested capital %
-17.4 K
-14.49 K
-24.16 K
-54.73 K
-36.29 K
-9 062.58
Gross margin %
100
—
100
100
—
—
Operating margin %
-38.24 K
—
-2 780.39
-1 033.19
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
38.1 K
—
2 783.85
1 039.51
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
21.79
11.52
9.34
13.7
11.16
48.29
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
—
0.02
0.05
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
0.97
1.53
1.55
2.48
2.52
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.5
3.06
4.6
4.71
16.7
Net current asset value per share
—
4.68
3.29
4.82
5.06
17.93
Tangible book value per share
—
4.28
2.95
4.47
4.67
16.65
Working capital per share
—
4.27
2.93
4.47
4.61
16.44
Book value per share
—
4.28
2.95
4.47
4.67
16.65
Nachrichten
Immunovant stock hits 52-week high at 28.32 USD
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Immunovant-Aktie erreicht neues Allzeithoch bei 27,87 USD
Immunovant stock hits all-time high at 27.87 USD
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Roivant Sciences: Positive Brepocitinib-Daten treiben die Pipeline-Dynamik voran
Immunovant übertrifft Gewinnerwartungen: Aktie legt nach Q3-Zahlen deutlich zu
Immunovant übertrifft Prognosen: Aktie legt nach geringerem Quartalsverlust um 7 % zu/n
Immunovant shares jump 7% as Q3 loss narrows, beats estimates